한글목차

소토라십 정제 시장 규모는 최근 급성장하고 있습니다. 2025년 19억 2,000만 달러에서 2026년에는 21억 6,000만 달러에 이르고, CAGR 12.3%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 비소세포폐암 진단 증가, KRAS 돌연변이 연구의 진전, 표적항암제의 규제당국 승인, 분자진단 능력의 확대, 종양학 임상시험 증가에 기인하는 것으로 보입니다.

소토라십 정제 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 34억 달러에 이르고, CAGR은 12.0%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 차세대 KRAS 억제제 개발 증가, 병용요법 접근법 확대, 추가 암 적응증에 대한 표적치료제 확대, 실제 데이터 연구 활용 증가, 종양학 분야 정밀의료 도입 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 KRAS G12C 억제제 요법의 도입 증가, 폐암 표적치료제에 대한 관심 증가, 경구용 항암제 사용 확대, 동반진단 검사 확대, 내성 기전 모니터링 강화 등이 있습니다.

암 발병률 증가는 향후 몇 년 동안 소토라시브 정제 시장의 성장을 견인할 것으로 예측됩니다. 암은 비정상적인 세포가 통제할 수 없을 정도로 증식하여 주변 조직에 침윤하고 체내 다른 부위로 전이될 가능성이 있는 질환군입니다. 암 발생 증가는 고령화에 기인하며, 고령은 대부분의 암 발생의 가장 중요한 위험 요소이며, 대부분의 암 발생은 65세 이상에서 발생합니다. 소틀라시브 정제는 KRAS G12C 돌연변이를 선택적으로 비가역적으로 표적화하여 돌연변이 단백질을 불활성 상태로 고정시킴으로써 진행성 고형암, 특히 비소세포폐암 환자에서 조절되지 않는 세포 증식을 억제합니다. 예를 들어, 2024년 2월 세계보건기구(WHO)는 2050년까지 신규 암 발병 건수가 3,500만 건을 넘어설 것으로 예측했습니다. 이는 2022년 추정치인 2,000만 건에서 77% 증가한 수치입니다. WHO는 스위스에 본부를 둔 국제기구로 세계 보건 정책 및 공중보건 이니셔티브에 중점을 둔 국제기구입니다. 그 결과, 암 유병률 증가는 소토라시브 정제 시장의 성장을 가속하고 있습니다.

향후 고령화 인구 증가가 소토라시브 정제 시장의 성장을 견인할 것으로 예측됩니다. 고령화 인구는 일반적으로 65세 이상의 연령층으로, 노화에 따른 생리적, 심리적, 사회적 변화를 겪을 수 있습니다. 고령화 인구 증가는 주로 평균 수명의 연장에 기인하며, 의료, 영양, 생활환경의 개선으로 더 많은 사람들이 더 오래 살 수 있게 되면서 인구에서 노인이 차지하는 비율이 증가하고 있습니다. 소틀라시브 정은 KRAS G12C 돌연변이 암을 표적으로 하여 고령층에 혜택을 제공합니다. 노화에 따른 취약성을 해결하고, 노인의 치료 결과를 개선하는 정밀의료를 제공합니다. 예를 들어, 영국 의회 하원도서관(영국 정부기관)의 2024년 7월 기준 자료에 따르면, 2022년 기준 영국의 65세 이상 인구는 1,270만 명(전체 인구의 19%)에 달할 전망입니다. 이 숫자는 2072년까지 2,210만 명(인구의 27%)으로 증가할 것으로 예측됩니다. 따라서, 고령 인구 증가는 소토라시브 정제 시장의 확대를 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 세계 시장 경쟁 벤치마킹과 대시보드

제38장 주요 인수합병(M&A)

제39장 시장 잠재력이 높은 국가, 부문, 전략

제40장 부록

영문목차

Sotorasib tablets are a prescription medication designed for the treatment of specific cases of non-small cell lung cancer in patients whose tumors have the KRAS G12C gene mutation. The drug works by attaching to the abnormal KRAS protein, blocking it from sending signals that promote the uncontrolled growth and survival of cancer cells. This targeted inhibition can decrease tumor activity, slow disease progression, and enhance treatment outcomes in patients with limited options using standard therapies.

The primary dosage forms of sotorasib tablets include 40 milligrams (mg), 120 milligrams (mg), 240 milligrams (mg), and other strengths. The 40 mg tablets provide a lower-strength option of the KRAS G12C inhibitor Lumakras, allowing precise dose adjustments to enhance safety and tolerability. Sotorasib is administered to patient populations such as adolescents, adults, and senior adults. It is supplied through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and other distribution networks, and is applied for conditions including non-small cell lung cancer, colorectal cancer, and other indications. The end-users consist of hospitals, oncology centers, clinics, and other healthcare providers.

Tariffs are impacting the sotorasib tablets market by increasing costs of imported active ingredients, formulation materials, clinical trial supplies, and specialized manufacturing inputs. North America and Europe are most affected due to reliance on globally sourced pharmaceutical components, while Asia-Pacific experiences export-related cost pressures. These tariffs are influencing drug pricing and market access strategies. However, they are also encouraging local production partnerships, domestic API manufacturing, and greater investment in regional pharmaceutical supply chains to improve long-term availability.

The sotorasib tablets market research report is one of a series of new reports from The Business Research Company that provides sotorasib tablets market statistics, including sotorasib tablets industry global market size, regional shares, competitors with a sotorasib tablets market share, detailed sotorasib tablets market segments, market trends and opportunities, and any further data you may need to thrive in the sotorasib tablets industry. This sotorasib tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sotorasib tablets market size has grown rapidly in recent years. It will grow from $1.92 billion in 2025 to $2.16 billion in 2026 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing diagnosis of non-small cell lung cancer, advancements in kras mutation research, regulatory approvals for targeted oncology drugs, expansion of molecular diagnostic capabilities, growth in oncology clinical trials.

The sotorasib tablets market size is expected to see rapid growth in the next few years. It will grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to increasing development of next-generation kras inhibitors, rising combination therapy approaches, expansion of targeted treatments into additional cancer indications, growing use of real-world evidence studies, increasing oncology precision medicine adoption. Major trends in the forecast period include increasing adoption of kras g12c inhibitor therapies, rising focus on targeted lung cancer treatments, growing use of oral oncology medications, expansion of companion diagnostic testing, enhanced monitoring of resistance mechanisms.

The increasing prevalence of cancer is expected to drive the growth of the sotorasib tablets market in the coming years. Cancer is a collection of diseases characterized by abnormal cells that grow uncontrollably, invade surrounding tissues, and can spread to other parts of the body. The rise in cancer cases is attributed to the aging population, as older age is the most significant risk factor for developing most types of cancer, with the majority of cases occurring in individuals over 65 years old. Sotorasib tablets act by selectively and irreversibly targeting the KRAS G12C mutation, locking the mutated protein in an inactive state to prevent uncontrolled cell growth in patients with advanced solid tumors, particularly non-small cell lung cancer. For example, in February 2024, the World Health Organization, a Switzerland-based international organization focused on global health policy and public health initiatives, projected over 35 million new cancer cases in 2050, representing a 77% increase from the estimated 20 million cases in 2022. Consequently, the rising prevalence of cancer is fueling the growth of the sotorasib tablets market.

The increasing geriatric population is expected to drive the growth of the sotorasib tablets market going forward. The geriatric population refers to older adults, generally aged 65 years and above, who may experience physiological, psychological, and social changes associated with aging. The rise in the geriatric population is mainly attributed to longer life expectancy, as improvements in healthcare, nutrition, and living conditions enable more people to live longer, resulting in a higher proportion of older adults within the population. Sotorasib tablets benefit the geriatric population by targeting KRAS G12C-mutated cancers, providing a precision therapy that addresses age-related vulnerabilities and enhances treatment outcomes in older adults. For example, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, there were 12.7 million people aged 65 or older in the UK in 2022, representing 19% of the total population. This number is projected to increase to 22.1 million by 2072, accounting for 27% of the population. Consequently, the growing geriatric population is fueling the expansion of the sotorasib tablets market.

Major companies operating in the sotorasib tablets market are concentrating on developing innovative therapies such as combination treatments to enhance efficacy and address resistance. Combination treatments involve using two or more drugs together to target cancer through multiple mechanisms simultaneously, helping to improve treatment effectiveness, overcome or delay drug resistance, reduce the risk of cancer recurrence, and enhance overall patient outcomes and quality of life. For example, in January 2025, Amgen Inc., a US-based biotechnology company, received U.S. Food and Drug Administration (FDA) approval for sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC) who had previously undergone standard chemotherapy. This approval was supported by the results of the Phase 3 CodeBreaK 300 study, which showed that the combination more than doubled progression-free survival compared to the investigator's choice of standard-of-care therapy, offering a significant new option for patients with this hard-to-treat cancer. Sotorasib is a first-in-class, oral KRAS G12C inhibitor that works by selectively targeting and locking the mutant KRAS protein in its inactive state, thereby inhibiting cancer cell growth and signaling pathways driven by this mutation.

Major companies operating in the sotorasib tablets market are Amgen Inc.

North America was the largest region in the sotorasib tablets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sotorasib tablets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sotorasib tablets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sotorasib tablets market consists of sales of lumakras, lumykras, and diagnostic companion kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sotorasib Tablets Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses sotorasib tablets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sotorasib tablets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sotorasib tablets market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Dosage Form: 40 Milligrams (Mg) Tablets; 120 Milligrams (Mg) Tablets; 240 Milligrams (Mg) Tablets; Other Dosage Forms
• 2) By Patient Demographics: Adolescents; Adult; Senior Adults
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 4) By Application: Non-Small Cell Lung Cancer; Colorectal Cancer; Other Applications
• 5) By End-User: Hospitals; Oncology Centers; Clinics; Other End-Users
• Companies Mentioned: Amgen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Sotorasib Tablets Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Sotorasib Tablets Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Sotorasib Tablets Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Sotorasib Tablets Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Fintech, Blockchain, Regtech & Digital Finance
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of KRAS G12C Inhibitor Therapies
  • 4.2.2 Rising Focus On Targeted Lung Cancer Treatments
  • 4.2.3 Growing Use Of Oral Oncology Medications
  • 4.2.4 Expansion Of Companion Diagnostic Testing
  • 4.2.5 Enhanced Monitoring Of Resistance Mechanisms

5. Sotorasib Tablets Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Oncology Centers
• 5.3 Specialty Clinics
• 5.4 Research Institutes
• 5.5 Pharmaceutical Companies

6. Sotorasib Tablets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sotorasib Tablets Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Sotorasib Tablets PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Sotorasib Tablets Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Sotorasib Tablets Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Sotorasib Tablets Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sotorasib Tablets Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sotorasib Tablets Market Segmentation

• 9.1. Global Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 40 Milligrams (Mg) Tablets, 120 Milligrams (Mg) Tablets, 240 Milligrams (Mg) Tablets, Other Dosage Forms
• 9.2. Global Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adolescents, Adult, Senior Adults
• 9.3. Global Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
• 9.4. Global Sotorasib Tablets Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Non-Small Cell Lung Cancer, Colorectal Cancer, Other Applications
• 9.5. Global Sotorasib Tablets Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Oncology Centers, Clinics, Other End-Users

10. Sotorasib Tablets Market Regional And Country Analysis

• 10.1. Global Sotorasib Tablets Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Sotorasib Tablets Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sotorasib Tablets Market

• 11.1. Asia-Pacific Sotorasib Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sotorasib Tablets Market

• 12.1. China Sotorasib Tablets Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sotorasib Tablets Market

• 13.1. India Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sotorasib Tablets Market

• 14.1. Japan Sotorasib Tablets Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sotorasib Tablets Market

• 15.1. Australia Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Sotorasib Tablets Market

• 16.1. Indonesia Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Sotorasib Tablets Market

• 17.1. South Korea Sotorasib Tablets Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Sotorasib Tablets Market

• 18.1. Taiwan Sotorasib Tablets Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Sotorasib Tablets Market

• 19.1. South East Asia Sotorasib Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Sotorasib Tablets Market

• 20.1. Western Europe Sotorasib Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Sotorasib Tablets Market

• 21.1. UK Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Sotorasib Tablets Market

• 22.1. Germany Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Sotorasib Tablets Market

• 23.1. France Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Sotorasib Tablets Market

• 24.1. Italy Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Sotorasib Tablets Market

• 25.1. Spain Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Sotorasib Tablets Market

• 26.1. Eastern Europe Sotorasib Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Sotorasib Tablets Market

• 27.1. Russia Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Sotorasib Tablets Market

• 28.1. North America Sotorasib Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Sotorasib Tablets Market

• 29.1. USA Sotorasib Tablets Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Sotorasib Tablets Market

• 30.1. Canada Sotorasib Tablets Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Sotorasib Tablets Market

• 31.1. South America Sotorasib Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Sotorasib Tablets Market

• 32.1. Brazil Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Sotorasib Tablets Market

• 33.1. Middle East Sotorasib Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Sotorasib Tablets Market

• 34.1. Africa Sotorasib Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Sotorasib Tablets Market, Segmentation By Dosage Form, Segmentation By Patient Demographics, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Sotorasib Tablets Market Regulatory and Investment Landscape

36. Sotorasib Tablets Market Competitive Landscape And Company Profiles

• 36.1. Sotorasib Tablets Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Sotorasib Tablets Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Sotorasib Tablets Market Company Profiles
  • 36.3.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Global Sotorasib Tablets Market Competitive Benchmarking And Dashboard

38. Key Mergers And Acquisitions In The Sotorasib Tablets Market

39. Sotorasib Tablets Market High Potential Countries, Segments and Strategies

• 39.1 Sotorasib Tablets Market In 2030 - Countries Offering Most New Opportunities
• 39.2 Sotorasib Tablets Market In 2030 - Segments Offering Most New Opportunities
• 39.3 Sotorasib Tablets Market In 2030 - Growth Strategies
  • 39.3.1 Market Trend Based Strategies
  • 39.3.2 Competitor Strategies

40. Appendix

• 40.1. Abbreviations
• 40.2. Currencies
• 40.3. Historic And Forecast Inflation Rates
• 40.4. Research Inquiries
• 40.5. The Business Research Company
• 40.6. Copyright And Disclaimer